drugset / Trial / NCT07319286

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

NCT07319286

Phase 1/2 Enrolling by invitation 50 enrolled Ain Shams University
RandomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to measure the frequency of menstrual irregularities among adolescent females with Type 1 diabetes mellitus and to assess the therapeutic effect of glucagon-like peptide-1 receptor agonist on menstrual irregularities in adolescent females with Type 1 diabetes mellitus .

Timeline

Start
2025-08-04
Primary completion
2026-12
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dulaglutide Peptide 1.5 mg